Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.971,63
-1,20%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ ARCA Biopharma Inc (ABIO) ARCA Biopharma Inc (ABIO) Notizie

ARCA Biopharma Inc

ABIO
3,58
0,10 (2,87%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202422:15GLOBEARCA biopharma Announces First Quarter 2024 Financial..
05/4/202419:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202413:30GLOBEARCA biopharma and Oruka Therapeutics Announce Merger..
07/2/202419:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:15EDGAR2Form 8-K - Current report
01/2/202422:39EDGAR2Form 8-K - Current report
01/2/202422:35GLOBEARCA biopharma Announces 2023 Financial Results
01/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/2/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:15EDGAR2Form 8-K - Current report
19/12/202322:25EDGAR2Form ARS - Annual Report to Security Holders
19/12/202322:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
05/12/202322:25EDGAR2Form 8-K - Current report
04/12/202322:36EDGAR2Form 8-K - Current report
18/10/202322:35EDGAR2Form 8-K - Current report
18/10/202322:25GLOBEARCA biopharma Announces Third Quarter 2023 Financial..
18/10/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/9/202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/7/202322:35EDGAR2Form 8-K - Current report
21/7/202322:25GLOBEARCA biopharma Announces Second Quarter 2023 Financial..
21/7/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 3,68 Min: 3,5001 Max: 3,68
Chiusura: 3,48

La tua Cronologia

NASDAQ
ABIO
ARCA Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network